(CELH) Celsius Holdings - Overview
Sector: Consumer Defensive | Industry: Beverages - Non-Alcoholic | Exchange: NASDAQ (USA) | Market Cap: 8.785m USD | Total Return: -2.3% in 12m
Industry Rotation: -9.0
Avg Turnover: 210M USD
Peers RS (IBD): 4.5
EPS Trend: 35.0%
Qual. Beats: 2
Rev. Trend: 89.3%
Qual. Beats: 1
Warnings
P/E ratio 136.3
Beneish M-Score -0.84 > -1.5 - likely earnings manipulation
Volatile
Tailwinds
No distinct edge detected
Celsius Holdings, Inc. manufactures and distributes functional energy drinks globally. The companys product portfolio includes CELSIUS branded energy drinks, specialized amino-infused beverages, and powdered hydration products. The functional beverage market is a growing segment within the broader non-alcoholic beverage industry.
Distribution channels are extensive, encompassing direct-to-store delivery, independent distributors, and a wide array of retail outlets including supermarkets, convenience stores, and e-commerce platforms. This multi-channel approach is common for consumer packaged goods companies aiming for broad market penetration.
To further understand CELHs market position, consider exploring its growth metrics on ValueRay.
- Distribution expansion into new markets drives revenue growth
- Increased competition in energy drink market impacts pricing
- Raw material cost fluctuations affect profit margins
- Regulatory scrutiny on energy drink ingredients poses risk
- Consumer health trends influence product demand
| Net Income: 108.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA -7.24 > 1.0 |
| NWC/Revenue: 29.12% < 20% (prev 70.75%; Δ -41.63% < -1%) |
| CFO/TA 0.07 > 3% & CFO 359.4m > Net Income 108.0m |
| Net Debt (271.1m) to EBITDA (189.9m): 1.43 < 3 |
| Current Ratio: 1.68 > 1.5 & < 3 |
| Outstanding Shares: last quarter (237.2m) vs 12m ago 25.65% < -2% |
| Gross Margin: 50.39% > 18% (prev 0.50%; Δ 4.99k% > 0.5%) |
| Asset Turnover: 73.05% > 50% (prev 76.72%; Δ -3.68% > 0%) |
| Interest Coverage Ratio: 3.28 > 6 (EBITDA TTM 189.9m / Interest Expense TTM 49.0m) |
| A: 0.14 (Total Current Assets 1.81b - Total Current Liabilities 1.08b) / Total Assets 5.12b |
| B: 0.03 (Retained Earnings 175.9m / Total Assets 5.12b) |
| C: 0.05 (EBIT TTM 160.5m / Avg Total Assets 3.44b) |
| D: 0.08 (Book Value of Equity 179.2m / Total Liabilities 2.18b) |
| Altman-Z'' Score: 1.45 = BB |
| DSRI: 1.51 (Receivables 755.5m/270.3m, Revenue 2.52b/1.36b) |
| GMI: 1.00 (GM 50.39% / 50.18%) |
| AQI: 3.05 (AQ_t 0.63 / AQ_t-1 0.21) |
| SGI: 1.86 (Revenue 2.52b / 1.36b) |
| TATA: -0.05 (NI 108.0m - CFO 359.4m) / TA 5.12b) |
| Beneish M-Score: -0.84 (Cap -4..+1) = D |
Over the past week, the price has changed by +6.75%, over one month by -16.00%, over three months by -31.23% and over the past year by -2.34%.
- StrongBuy: 8
- Buy: 6
- Hold: 6
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 67.5 | 85.4% |
P/E Forward = 22.2222
P/S = 3.4928
P/B = 7.467
P/EG = 0.3424
Revenue TTM = 2.52b USD
EBIT TTM = 160.5m USD
EBITDA TTM = 189.9m USD
Long Term Debt = 669.9m USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 669.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 271.1m USD (from netDebt column, last quarter)
Enterprise Value = 9.06b USD (8.79b + Debt 669.9m - CCE 398.9m)
Interest Coverage Ratio = 3.28 (Ebit TTM 160.5m / Interest Expense TTM 49.0m)
EV/FCF = 28.01x (Enterprise Value 9.06b / FCF TTM 323.4m)
FCF Yield = 3.57% (FCF TTM 323.4m / Enterprise Value 9.06b)
FCF Margin = 12.86% (FCF TTM 323.4m / Revenue TTM 2.52b)
Net Margin = 4.29% (Net Income TTM 108.0m / Revenue TTM 2.52b)
Gross Margin = 50.39% ((Revenue TTM 2.52b - Cost of Revenue TTM 1.25b) / Revenue TTM)
Gross Margin QoQ = 47.37% (prev 51.34%)
Tobins Q-Ratio = 1.77 (Enterprise Value 9.06b / Total Assets 5.12b)
Interest Expense / Debt = 1.89% (Interest Expense 12.7m / Debt 669.9m)
Taxrate = 13.62% (17.0m / 125.0m)
NOPAT = 138.6m (EBIT 160.5m * (1 - 13.62%))
Current Ratio = 1.68 (Total Current Assets 1.81b / Total Current Liabilities 1.08b)
Debt / Equity = 0.23 (Debt 669.9m / totalStockholderEquity, last quarter 2.94b)
Debt / EBITDA = 1.43 (Net Debt 271.1m / EBITDA 189.9m)
Debt / FCF = 0.84 (Net Debt 271.1m / FCF TTM 323.4m)
Total Stockholder Equity = 2.32b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.14% (Net Income 108.0m / Total Assets 5.12b)
RoE = 4.66% (Net Income TTM 108.0m / Total Stockholder Equity 2.32b)
RoCE = 5.37% (EBIT 160.5m / Capital Employed (Equity 2.32b + L.T.Debt 669.9m))
RoIC = 8.54% (NOPAT 138.6m / Invested Capital 1.62b)
WACC = 10.63% (E(8.79b)/V(9.46b) * Re(11.32%) + D(669.9m)/V(9.46b) * Rd(1.89%) * (1-Tc(0.14)))
Discount Rate = 11.32% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 81.65 | Cagr: 3.73%
[DCF] Terminal Value 73.49% ; FCFF base≈289.8m ; Y1≈357.5m ; Y5≈610.0m
[DCF] Fair Price = 25.24 (EV 6.76b - Net Debt 271.1m = Equity 6.49b / Shares 257.0m; r=10.63% [WACC]; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 35.02 | EPS CAGR: 34.61% | SUE: 0.93 | # QB: 2
Revenue Correlation: 89.32 | Revenue CAGR: 56.86% | SUE: 2.12 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.47 | Chg7d=-0.001 | Chg30d=-0.001 | Revisions Net=+1 | Analysts=16
EPS current Year (2026-12-31): EPS=1.63 | Chg7d=-0.002 | Chg30d=+0.010 | Revisions Net=+10 | Growth EPS=+21.7% | Growth Revenue=+34.9%
EPS next Year (2027-12-31): EPS=2.05 | Chg7d=-0.003 | Chg30d=+0.016 | Revisions Net=+10 | Growth EPS=+25.8% | Growth Revenue=+10.0%
[Analyst] Revisions Ratio: +0.11 (5 Up / 4 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 10.6% (Discount Rate 11.3% - Earnings Yield 0.7%)
[Growth] Growth Spread = +13.6% (Analyst 24.2% - Implied 10.6%)